2016
DOI: 10.5507/bp.2016.038
|View full text |Cite
|
Sign up to set email alerts
|

Significant phenotype variability of congenital central hypoventilation syndrome in a family with polyalanine expansion mutation of the PHOX2B gene

Abstract: Background. Congenital central hypoventilation syndrome (CCHS) is a rare genetic disorder resulting from mutations in the PHOX2B gene located on chromosome 4p12.3, characterized by hypoventilation secondary to missing responses to both hypercapnia and hypoxia. Case report. Proband. A girl, hospitalised 5 times for respiratory failure from 6 weeks old, presented at 4 years of age severe cyanosis related to pneumonia. Tracheostomy was done, and she was discharged home using a portable positive pressure ventilato… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 21 publications
0
5
0
Order By: Relevance
“…Therefore, mutations associated with homeobox genes can lead to devastating neurological defects. Two such genes, ARX and SOX3 , are involved in development of the central nervous system and function as transcription factors containing several poly-Ala stretches [ 71 , 72 ]. Expansion of the poly-Ala stretch in SOX3 protein is associated with X-linked mental retardation with growth hormone deficiency as well as X-linked hypopituitarism [ 72 , 74 ].…”
Section: Polyalanine Repeat Expansionsmentioning
confidence: 99%
“…Therefore, mutations associated with homeobox genes can lead to devastating neurological defects. Two such genes, ARX and SOX3 , are involved in development of the central nervous system and function as transcription factors containing several poly-Ala stretches [ 71 , 72 ]. Expansion of the poly-Ala stretch in SOX3 protein is associated with X-linked mental retardation with growth hormone deficiency as well as X-linked hypopituitarism [ 72 , 74 ].…”
Section: Polyalanine Repeat Expansionsmentioning
confidence: 99%
“…Approximately 10% of patients have a non-polyalanine repeat mutation (NPARM) in the PHOX2B gene, which is generally reported to be associated with a more severe phenotype. 1 Only a few familial cases of CCHS with confirmed PHOX2B gene mutations have been previously reported in the literature, [2][3][4][5][6][7] only two of which involve the PHOX2B NPARM mutation. 4,5 In these two familial cases, Hirschsprung disease as well as respiratory control symptoms were prominent.…”
Section: Introductionmentioning
confidence: 99%
“…This highlights the importance of screening family members of patients with CCHS to minimize the future incidence of pulmonary compromise. Abnormalities on the PSG findings in 5 of the remaining 27 undiagnosed patients in group B were observed, 10,[15][16][17][18] but the abnormal findings of PSG in patient #B-16 were not detected. 10 This might suggest that usual overnight PSG (ie, without monitoring for CO 2 ) will not sufficiently detect the alveolar hypoventilation associated with CCHS.…”
Section: Discussionmentioning
confidence: 83%
“…Five of the PHOX2B-mutation carriers were treated with NPPV or CPAP for obstructive sleep apnea syndrome or other unreported reasons. 15,16,18 However, since these carriers are at risk of developing CCHS, close monitoring, investigation, and early initiation of the therapy (particularly with illness or exposure to sedative medications) are warranted. In addition, although CPAP has been introduced for the treatment of OSA in some carriers, we think that its use would be insufficient to treat hypoventilation (ie, no increase in minute ventilation with hypercapnia and hypoxia; no backup rate) if an association with CCHS is likely.…”
Section: Discussionmentioning
confidence: 99%